Evaluation of Asymptomatic Microscopic Hematuria in Adults

Am Fam Physician. 1999 Sep 15;60(4):1143-1152.

  See related patient information handout on microscopic hematuria, written by the authors of this article.

In patients without significant urologic symptoms, microscopic hematuria is occasionally detected on routine urinalysis. At present, routine screening of all adults for microscopic hematuria with dipstick testing is not recommended because of the intermittent occurrence of this finding and the low incidence of significant associated urologic disease. However, once asymptomatic microscopic hematuria is discovered, its cause should be investigated with a thorough medical history (including a review of current medications) and a focused physical examination. Laboratory and imaging studies, such as intravenous pyelography, renal ultrasonography or retrograde pyelography, may be required to determine the degree and location of the associated disease process. Cystourethroscopy is performed to complete the evaluation of the lower urinary tract. Microscopic hematuria associated with anticoagulation therapy is frequently precipitated by significant urologic pathology and therefore requires prompt evaluation.

Microscopic hematuria is defined as the excretion of more than three red blood cells per high-power field in a centrifuged urine specimen.1 Because the degree of hematuria bears no relation to the seriousness of the underlying cause, hematuria should be considered a symptom of serious disease until proved otherwise.

The widespread use of dipstick urinalysis in clinical practice and health screening has resulted in increased recognition of microscopic hematuria and has raised concerns about the appropriate diagnostic investigation. The prevalence of asymptomatic microscopic hematuria in adult men and postmenopausal women has been reported to range from 10 percent to as high as 20 percent.24 Routine screening of all adults for microscopic hematuria with dipstick testing is not currently recommended because of the intermittent occurrence of this finding and the low incidence of significant associated urologic disease.

Detection of Hematuria

DIPSTICK TESTS FOR HEMATURIA

In clinical practice, dipstick urinalysis is the test most commonly used to detect urinary tract disorders in asymptomatic patients. In this test, cellulose strips dipped into a urine specimen record the ability of hemoglobin to catalyze the reaction between hydrogen peroxide and a chromogen. The resulting reaction causes the chromogen to turn green, with the degree of color change directly related to the amount of hemoglobin present in the urine specimen. A spotted pattern to the dipstick indicates the presence of free hemoglobin.5,6

Dipstick testing has been shown to be 91 to 100 percent sensitive and 65 to 99 percent specific for the detection of hemoglobin.7 False-positive test results have been reported in the presence of myoglobinuria and oxidizing contaminants (e.g., hypochlorite, povidone and bacterial peroxidases), contamination of the urine specimen with menstrual blood, and dehydration with elevation of urine specific gravity.1,5 False-negative results have been reported in the presence of reducing agents (e.g., ascorbic acid), a urinary pH of less than 5.1 and dip-sticks that have been exposed to air.1,5

URINE SPECIMEN COLLECTION AND PREPARATIONS

Several factors can influence the microscopic detection of erythrocytes in urine. Procurement of a urine sample using a catheter may cause urethral trauma that results in variable degrees of hematuria. A clean-catch midstream urine specimen should be obtained using aseptic technique to avoid contamination from the external genitalia. The first urine in the morning is typically the best specimen because erythrocytes are heat preserved in acidic and concentrated urine.

A prolonged delay from specimen collection to analysis can result in a false test interpretation. When a urine specimen cannot be examined within one hour of collection, it should be refrigerated to prevent overgrowth of bacteria, changes in urinary pH and disintegration of red and white cell casts. These conditions may occur if the specimen remains at room temperature for a long period.

Standardization of the analysis procedure is also essential to achieve an accurate result. Centrifugation is typically performed on a fixed volume of urine (5 mL) for five minutes at 3,000 rotations per minute, after which the supernatant is poured off and the remaining sediment is resuspended in the centrifuge tube by gently tapping the bottom of the tube. A pipette is used to sample the residual fluid and transfer it to a glass slide; a cover-slip is applied to the slide for the microscopic evaluation.5 The specimen is examined under high magnification (× 400) to determine cell type and distinct morphologic features. Results are recorded as the number of red blood cells per high-power field.

FINDINGS ON MICROSCOPY

On phase contrast microscopy, erythrocytes may display morphologic features that are helpful in differentiating glomerular and nonglomerular causes of microscopic hematuria8 (Figures 1 and 2).

FIGURE 1.

Typical morphology of erythrocytes from a urine specimen revealing microscopic hematuria. (phase contrast microscopy, ×100)

View Large


FIGURE 1.

Typical morphology of erythrocytes from a urine specimen revealing microscopic hematuria. (phase contrast microscopy, ×100)


FIGURE 1.

Typical morphology of erythrocytes from a urine specimen revealing microscopic hematuria. (phase contrast microscopy, ×100)

FIGURE 2.

Dysmorphic erythrocytes from a urine specimen. These cells suggest a glomerular cause of microscopic hematuria. (phase contrast microscopy, × 100)

View Large


FIGURE 2.

Dysmorphic erythrocytes from a urine specimen. These cells suggest a glomerular cause of microscopic hematuria. (phase contrast microscopy, × 100)


FIGURE 2.

Dysmorphic erythrocytes from a urine specimen. These cells suggest a glomerular cause of microscopic hematuria. (phase contrast microscopy, × 100)

Dysmorphic erythrocytes are characterized by an irregular outer cell membrane and suggest hematuria of glomerular origin. Red blood cell casts are also associated with a glomerular cause of hematuria. Acanthocytes, which are ring-formed erythrocytes with one or more membrane protrusions of variable size and shape, may represent an early form of dysmorphic erythrocytes and are a marker for hematuria of glomerular origin.

Erythrocytes of uniform character are classified as isomorphic and suggest hematuria of lower urinary tract origin. Microscopic clots of clumped erythrocytes in urine are also suggestive of lower urinary tract bleeding.

The presence of both dysmorphic and isomorphic erythrocytes in urine represents a mixed morphologic pattern of nonspecific origin.

Diagnosis of Hematuria

HISTORY AND PHYSICAL EXAMINATION

The initial step in the evaluation of microscopic hematuria is a thorough medical history, including a review of prescription and nonprescription medications, a history of ingestion of certain foods and an inquiry for specific conditions (Tables 1 and 2).9,10

TABLE 1

Substances and Medications Affecting Urine Color

Artificial food coloring

Beets

Berries

Chloroquine (Aralen)

Furazolidone (Furoxone)

Hydroxychloroquine (Plaquenil)

Nitrofurantoin (Furadantin)

Phenazopyridine (Pyridium)

Phenolphthalein

Rifampin (Rifadin)


Information from Restrepo NC, Carey PO. Evaluating hematuria in adults. Am Fam Physician 1989; 40(2):149–56, and Drugdex system. Englewood: Colo.: Micromedex, Inc., 1999. Accessed Sept. 24, 1998.

TABLE 1   Substances and Medications Affecting Urine Color

View Table

TABLE 1

Substances and Medications Affecting Urine Color

Artificial food coloring

Beets

Berries

Chloroquine (Aralen)

Furazolidone (Furoxone)

Hydroxychloroquine (Plaquenil)

Nitrofurantoin (Furadantin)

Phenazopyridine (Pyridium)

Phenolphthalein

Rifampin (Rifadin)


Information from Restrepo NC, Carey PO. Evaluating hematuria in adults. Am Fam Physician 1989; 40(2):149–56, and Drugdex system. Englewood: Colo.: Micromedex, Inc., 1999. Accessed Sept. 24, 1998.

TABLE 2

Mechanisms by Which Selected Drugs May Cause Hematuria

Mechanism Drugs

Interstitial nephritis

Captopril (Capoten)

Cephalosporins

Chlorothiazide (Diuril)

Ciprofloxacin (Cipro)

Furosemide (Lasix)

NSAIDs

Olsalazine (Dipentum)

Omeprazole (Prilosec)

Penicillins

Rifampin (Rifadin)

Silver sulfadiazine (Silvadene)

Trimethoprim-sulfamethoxazole (Bactrim, Septra)

Papillary necrosis

Acetylsalicylic acid (aspirin)

NSAIDs

Hemorrhagic cystitis

Cyclophosphamide (Cytoxan)

Ifosfamide (Ifex)

Mitotane (Lysodren)

Urolithiasis

Carbonic anhydrase inhibitors

Dichlorphenamide (Daranide)

Indinavir (Crixivan)

Mirtazapine (Remeron)

Ritonavir (Norvir)

Triamterene (Dyrenium)


NSAIDs = nonsteroidal anti-inflammatory drugs.

Information from Restrepo NC, Carey PO. Evaluating hematuria in adults. Am Fam Physician 1989; 40(2):149–56, and Drugdex system. Englewood: Colo.: Micromedex, Inc., 1999. Accessed Sept. 24, 1998.

TABLE 2   Mechanisms by Which Selected Drugs May Cause Hematuria

View Table

TABLE 2

Mechanisms by Which Selected Drugs May Cause Hematuria

Mechanism Drugs

Interstitial nephritis

Captopril (Capoten)

Cephalosporins

Chlorothiazide (Diuril)

Ciprofloxacin (Cipro)

Furosemide (Lasix)

NSAIDs

Olsalazine (Dipentum)

Omeprazole (Prilosec)

Penicillins

Rifampin (Rifadin)

Silver sulfadiazine (Silvadene)

Trimethoprim-sulfamethoxazole (Bactrim, Septra)

Papillary necrosis

Acetylsalicylic acid (aspirin)

NSAIDs

Hemorrhagic cystitis

Cyclophosphamide (Cytoxan)

Ifosfamide (Ifex)

Mitotane (Lysodren)

Urolithiasis

Carbonic anhydrase inhibitors

Dichlorphenamide (Daranide)

Indinavir (Crixivan)

Mirtazapine (Remeron)

Ritonavir (Norvir)

Triamterene (Dyrenium)


NSAIDs = nonsteroidal anti-inflammatory drugs.

Information from Restrepo NC, Carey PO. Evaluating hematuria in adults. Am Fam Physician 1989; 40(2):149–56, and Drugdex system. Englewood: Colo.: Micromedex, Inc., 1999. Accessed Sept. 24, 1998.

The information obtained in the medical history is used to screen for the multiple potential causes of both glomerular and nonglomerular conditions that can lead to microscopic hematuria (Table 3).1115  IgA nephropathy (Berger's disease) is the most common cause of glomerular hematuria. Drug-induced glomerular causes of hematuria include nonsteroidal anti-inflammatory drugs and certain antibiotics associated with analgesic nephropathy and interstitial nephritis (Table 2).9,10

TABLE 3

Glomerular and Nonglomerular Causes of Hematuria

Glomerular causes

Primary glomerulonephritis

IgA nephropathy (Berger's disease)

Postinfectious glomerulonephritis

Membranoproliferative glomerulonephritis

Focal glomerular sclerosis

Rapidly progressing glomerulonephritis

Secondary glomerulonephritis

Lupus nephritis

Henoch-Schönlein syndrome

Vasculitis (polyarteritis nodosa, Wegener's granulomatosis)

Essential mixed cryoglobulinemia

Hemolyticuremic syndrome

Thrombotic thrombocytopenic purpura

Medications (i.e., interstitial nephritis, analgesic nephropathy)

Familial conditions

Thin glomerular basement membrane nephropathy

Hereditary nephritis (Alport's syndrome)

Fabry's disease

Exercise1214

Nonglomerular causes

Conditions affecting renal parenchyma

Renal tumors (renal cell carcinoma, angiomyolipoma, oncocytoma)

Vascular disorders (nutcracker syndrome,15 malignant hypertension, sickle cell trait or disease, arteriovenous malformation, renal vein thrombosis or infarct, transplant rejection)

Metabolic disorder (hypercalciuria, hyperuricuria)

Familial condition (polycystic kidney disease, medullary Sponge kidney)

Infection (acute or chronic pyelonephritis, tuberculosis, cytomegalovirus infection, infectious mononucleosis)

Papillary necrosis

Extrarenal conditions

Tumors (renal pelvis, ureter, bladder, prostate)

Benign prostatic hyperplasia

Stone or foreign body

Infections (cystitis, prostatitis, urinary schistosomiasis, tuberculosis, condyloma acuminatum)

Systemic bleeding disorder or coagulopathy

Trauma

Radiation therapy

Indwelling catheters

Drugs (heparin, warfarin [Coumadin], cyclophosphamide [Cytoxan])


Adapted with permission from Ahmed Z, Lee J. Asymptomatic urinary abnormalities. Hematuria and proteinuria. Med Clin North Am 1997;81:641–52; additional information from references 12 through 15.

TABLE 3   Glomerular and Nonglomerular Causes of Hematuria

View Table

TABLE 3

Glomerular and Nonglomerular Causes of Hematuria

Glomerular causes

Primary glomerulonephritis

IgA nephropathy (Berger's disease)

Postinfectious glomerulonephritis

Membranoproliferative glomerulonephritis

Focal glomerular sclerosis

Rapidly progressing glomerulonephritis

Secondary glomerulonephritis

Lupus nephritis

Henoch-Schönlein syndrome

Vasculitis (polyarteritis nodosa, Wegener's granulomatosis)

Essential mixed cryoglobulinemia

Hemolyticuremic syndrome

Thrombotic thrombocytopenic purpura

Medications (i.e., interstitial nephritis, analgesic nephropathy)

Familial conditions

Thin glomerular basement membrane nephropathy

Hereditary nephritis (Alport's syndrome)

Fabry's disease

Exercise1214

Nonglomerular causes

Conditions affecting renal parenchyma

Renal tumors (renal cell carcinoma, angiomyolipoma, oncocytoma)

Vascular disorders (nutcracker syndrome,15 malignant hypertension, sickle cell trait or disease, arteriovenous malformation, renal vein thrombosis or infarct, transplant rejection)

Metabolic disorder (hypercalciuria, hyperuricuria)

Familial condition (polycystic kidney disease, medullary Sponge kidney)

Infection (acute or chronic pyelonephritis, tuberculosis, cytomegalovirus infection, infectious mononucleosis)

Papillary necrosis

Extrarenal conditions

Tumors (renal pelvis, ureter, bladder, prostate)

Benign prostatic hyperplasia

Stone or foreign body

Infections (cystitis, prostatitis, urinary schistosomiasis, tuberculosis, condyloma acuminatum)

Systemic bleeding disorder or coagulopathy

Trauma

Radiation therapy

Indwelling catheters

Drugs (heparin, warfarin [Coumadin], cyclophosphamide [Cytoxan])


Adapted with permission from Ahmed Z, Lee J. Asymptomatic urinary abnormalities. Hematuria and proteinuria. Med Clin North Am 1997;81:641–52; additional information from references 12 through 15.

One common nonglomerular medical cause of hematuria is papillary necrosis. This condition should be considered in patients with diabetes mellitus, black patients with sickle cell trait or disease, and patients known to be analgesic abusers. Other common nonglomerular causes of hematuria include urothelial tumors, urolithiasis, benign prostatic hyperplasia (BPH) and urinary tract infection.

The physical examination should take into account the multiple potential causes of hematuria and include the following points: evaluation of the cardiovascular system for irregular cardiac rhythm, heart murmur or hypertension; evaluation of the abdomen for organomegaly or flank mass; evaluation of the prostate and external genitalia; and evaluation of the extremities for peripheral edema, petechiae or mottling (Table 4).

TABLE 4

Physical Examination Findings and Associated Causes of Hematuria

Physical examination finding Cause of hematuria

General (systemic) examination

Severe dehydration

Renal vein thrombosis

Peripheral edema

Nephrotic syndrome, vasculitis

Cardiovascular system

Myocardial infarction

Renal artery embolus or thrombus

Atrial fibrillation

Renal artery embolus or thrombus

Hypertension

Glomerulosclerosis with or without proteinuria

Abdomen

Bruit

Arteriovenous fistula

Genitourinary system

Enlarged prostate

Urinary tract infection

Phimosis

Urinary tract infection

Meatal stenosis

Urinary tract infection

TABLE 4   Physical Examination Findings and Associated Causes of Hematuria

View Table

TABLE 4

Physical Examination Findings and Associated Causes of Hematuria

Physical examination finding Cause of hematuria

General (systemic) examination

Severe dehydration

Renal vein thrombosis

Peripheral edema

Nephrotic syndrome, vasculitis

Cardiovascular system

Myocardial infarction

Renal artery embolus or thrombus

Atrial fibrillation

Renal artery embolus or thrombus

Hypertension

Glomerulosclerosis with or without proteinuria

Abdomen

Bruit

Arteriovenous fistula

Genitourinary system

Enlarged prostate

Urinary tract infection

Phimosis

Urinary tract infection

Meatal stenosis

Urinary tract infection

Urothelial cancers should also be considered in the evaluation of microscopic hematuria. Risk factors for these malignancies, particularly transitional cell carcinoma, are listed in Table 5.16

TABLE 5

Risk Factors for Urothelial Carcinoma

Cigarette smoking

Occupational exposures

Aniline dyes

Aromatic amines

Benzidine

Dietary nitrites and nitrates

Analgesic abuse (e.g., phenacetin)

Chronic cystitis and bacterial infection associated with urinary calculi and obstruction of the upper urinary tract

Urinary schistosomiasis

Cyclophosphamide (Cytoxan)

Pelvic irradiation


Information from Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Walsh PC, ed. Campbell's Urology. 7th ed. Philadelphia: Saunders, 1998:2327–410.

TABLE 5   Risk Factors for Urothelial Carcinoma

View Table

TABLE 5

Risk Factors for Urothelial Carcinoma

Cigarette smoking

Occupational exposures

Aniline dyes

Aromatic amines

Benzidine

Dietary nitrites and nitrates

Analgesic abuse (e.g., phenacetin)

Chronic cystitis and bacterial infection associated with urinary calculi and obstruction of the upper urinary tract

Urinary schistosomiasis

Cyclophosphamide (Cytoxan)

Pelvic irradiation


Information from Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Walsh PC, ed. Campbell's Urology. 7th ed. Philadelphia: Saunders, 1998:2327–410.

LABORATORY TESTS

The initial laboratory studies are determined by pertinent information obtained from the medical history and physical examination. Formal urinalysis is performed to document the degree of hematuria, determine the morphologic features of erythrocytes and evaluate urinary crystals and casts. If pyuria or bacteriuria is present, a urine culture with sensitivity testing should be obtained to rule out infectious urinary tract pathogens. Screening laboratory tests typically consist of coagulation studies, a complete blood count, serum chemistries and serologic studies for glomerular causes of hematuria as directed by the medical history.

Further urologic evaluation is warranted if more than three red blood cells per high-power field are found on at least two of three properly collected urine specimens or if high-grade microscopic hematuria (more than 100 red blood cells per high-power field) is found on a single urinalysis.17 The only exceptions are children with persistent microscopic hematuria without proteinuria, in whom the most likely diagnoses include thin glomerular basement membrane nephropathy, idiopathic hypercalciuria, IgA nephropathy and Alport's syndrome.

RADIOGRAPHIC INVESTIGATION

The initial radiographic study is intravenous pyelography (IVP), or excretory urography. The purpose of the study is to obtain an anatomic and functional evaluation of the upper and lower urinary tract. Before IVP is performed, the collected urine specimen should undergo microscopic examination to exclude an infectious cause of hematuria. Some centers use renal ultrasonography as an initial test to avoid exposing patients to intravenous contrast media; however, subtle findings in the renal collecting system may be difficult to detect by ultrasonography alone.

Risk factors for contrast uropathy have been described (Table 6).18 Because preexisting renal insufficiency is the most important risk factor for renal failure, the serum creatinine concentration should always be measured before any contrast examination is performed. Early studies reported a 4.7 percent overall incidence of adverse reactions to conventional ionic high-osmolar contrast media.19 Although most of these reactions were considered minor, true anaphylactic reactions have been described. The incidence of death after the intravenous administration of conventional contrast media has been reported to be one case per 40,000 contrast-material injections.19 Newer, non-ionic low-osmolar contrast media are associated with fewer adverse effects than traditional, less expensive, ionic high-osmolar agents.20

TABLE 6

Risk Factors for Contrast Uropathy

Dehydration

Diabetes with azotemia

Cardiac decompensation

History of allergy

Asthma

Hay fever

Seafood allergy

Others, including allergic reactions to antibiotics

Previous reaction to contrast media

Renal insufficiency


Information from Friedenberg RM. Excretory urography in the adult. In: Walsh PC, ed. Campbell's Urology. 6th ed. Philadelphia: Saunders, 1992:412–34.

TABLE 6   Risk Factors for Contrast Uropathy

View Table

TABLE 6

Risk Factors for Contrast Uropathy

Dehydration

Diabetes with azotemia

Cardiac decompensation

History of allergy

Asthma

Hay fever

Seafood allergy

Others, including allergic reactions to antibiotics

Previous reaction to contrast media

Renal insufficiency


Information from Friedenberg RM. Excretory urography in the adult. In: Walsh PC, ed. Campbell's Urology. 6th ed. Philadelphia: Saunders, 1992:412–34.

Metformin (Glucophage) is an oral antihyperglycemic agent commonly used in the management of type 2 diabetes (formerly termed non–insulin-dependent diabetes). This drug is eliminated primarily by the kidneys. [corrected] Because of potential exacerbation of acute renal failure and lactic acidosis, metformin should be discontinued at the time of radiologic studies involving intravascular administration of iodinated contrast materials and withheld for 48 hours subsequent to the procedure. It should be reinstituted only after renal function has been reevaluated and found to be normal.21

With excretory urography, tomography is typically performed to increase recognition of renal masses, fine renal calcifications and paranephric structures. Oblique images are obtained to assist in evaluation of ureteral lesions, differentiation of extrinsic and intrinsic renal or ureteral masses and visualization of the posterolateral aspect of the bladder. Delayed images are helpful in cases of obstruction in which the nephrogram phase is seen on IVP but the collecting system is not yet visualized.18

If the use of intravenous contrast material is contraindicated or if incomplete visualization of the lower urinary tract occurs, retrograde pyelography should be performed. Typically, the combination of retrograde pyelography and ultrasonography is employed to increase sensitivity in the detection of solid renal masses. However, renal ultrasonography cannot detect the subtle mucosal abnormalities that occur with transitional cell carcinoma or small, echogenic ureteral calculi. Compared with renal ultrasonography, computed tomography (CT) is more sensitive in detecting renal masses and subtle filling defects of the renal collecting system.22 Recently, unenhanced helical CT scans have provided accurate evaluation of patients with acute flank pain through the precise determination of calculus size and location.23 Despite advancements in radiographic imaging, the role of CT or ultrasonography as the primary imaging modality in the work-up of microscopic hematuria has not been established.

LOWER URINARY TRACT INVESTIGATION

Whereas radiographic imaging allows evaluation of the upper urinary tract, cystourethroscopy provides definitive evaluation of the lower urinary tract. In addition to direct visualization of the urethra, prostate and bladder, washings and biopsies of suspicious bladder lesions can be performed during cystourethroscopy.

Cytology obtained from washings is useful in detecting poorly differentiated sessile and in situ bladder lesions. With in situ bladder cancer, the results of cytologic analysis are often positive before lesions are seen with cystoscopy.1

OTHER INVESTIGATIONS

When no cause for microscopic hematuria is found with cystourethroscopy and appropriate radiographic imaging, further studies may be considered. These studies include CT scanning, renal angiography and flexible ureterorenoscopy. No consensus has been reached on the indications for renal biopsy in patients with hematuria, but this procedure may be indicated to rule out glomerular causes of hematuria.1 Despite a complete and exhaustive work-up, no specific cause is identified in approximately 20 percent of patients with microscopic hematuria.24

Molecular markers recently introduced into clinical practice to assist with the follow-up evaluation of urothelial carcinomas have yet to be labeled for the evaluation of hematuria. The two assays currently labeled for clinical use by the U.S. Food and Drug Administration are the bladder tumor antigen (BTA) test and the nuclear matrix protein (NMP-22) test.17,25 The BTA test is a latex agglutination assay for the qualitative detection of a basement membrane antigen in a voided urine specimen. The NMP-22 test involves the quantitative detection of a specific nuclear matrix protein in a voided urine specimen. Although these assays offer great potential for the early detection of recurrent bladder carcinoma, their role in the evaluation of hematuria is still uncertain.

A standard reference algorithm for the evaluation and treatment of asymptomatic microscopic hematuria is presented in Figure 3. This systematic approach can be useful in identifying and managing causes of hematuria ranging from infection to BPH26 to cancer.

Hematuria

FIGURE 3.

Algorithm for the evaluation and treatment of hematuria. (RBC = red blood cell; WBC = white blood cell; BUN = blood urea nitrogen; CBC = complete blood count; PT = prothrombin time; PTT = partial thromboplastin time; IVP = intravenous pyelography; KUB = plain radiograph of kidney, ureter and bladder; CT = computed tomography; TURP = transurethral resection of the prostate)

View Large

Hematuria


FIGURE 3.

Algorithm for the evaluation and treatment of hematuria. (RBC = red blood cell; WBC = white blood cell; BUN = blood urea nitrogen; CBC = complete blood count; PT = prothrombin time; PTT = partial thromboplastin time; IVP = intravenous pyelography; KUB = plain radiograph of kidney, ureter and bladder; CT = computed tomography; TURP = transurethral resection of the prostate)

Hematuria


FIGURE 3.

Algorithm for the evaluation and treatment of hematuria. (RBC = red blood cell; WBC = white blood cell; BUN = blood urea nitrogen; CBC = complete blood count; PT = prothrombin time; PTT = partial thromboplastin time; IVP = intravenous pyelography; KUB = plain radiograph of kidney, ureter and bladder; CT = computed tomography; TURP = transurethral resection of the prostate)

Special Considerations

HEMATURIA DURING ANTICOAGULATION

Microscopic hematuria is commonly encountered in patients taking anticoagulant drugs. Although it may be easy to attribute this hematuria solely to anticoagulation therapy, significant urologic causes have been reported in 13 to 45 percent of such patients.27,28 Current recommended anticoagulation schedules do not predispose patients to hematuria.27 The most common causes of anticoagulant-associated hematuria include BPH, inflammatory conditions, urolithiasis, papillary necrosis and cancers of the upper and lower urinary tract.

HEMATURIA FOLLOWING EXERCISE

Asymptomatic microscopic hematuria resulting from strenuous exercise has been well documented in association with a variety of contact and noncontact sports activities.1214 The degree of hematuria is believed to be related to the intensity and duration of exercise.12 Although exercise-induced hematuria is typically a benign, self-limited process, coexisting urinary tract pathology may exist and must be carefully excluded.

Exercise-induced microscopic hematuria almost always resolves within 72 hours of onset in patients who do not have underlying urinary tract abnormality. However, if the hematuria is present on repeat urinalysis after 72 hours of rest, further urologic evaluation may be indicated.

Final Comment

Asymptomatic microscopic hematuria is commonly nephric in origin, whereas gross hematuria is often uroepithelial in origin. Gross, painless hematuria is often the first manifestation of a urothelial tumor. However, the degree of hematuria bears no relation to the seriousness of the underlying disease. Consequently, the microscopic finding of blood in the urine should be considered a serious symptom until significant pathology has been excluded.

Phase contrast microscopy is currently the best initial method of documenting microscopic hematuria. The evaluation often includes intravenous pyelography, cystourethroscopy and urinary cytology.

Unfortunately, consensus is lacking regarding the management of persistent asymptomatic microscopic hematuria of unknown etiology. Recommended surveillance schedules for patients with a previous negative evaluation for unexplained microscopic hematuria include urinalysis and voided urinary cytology annually until the hematuria resolves, or for up to three years if microscopic hematuria persists. Any significant increase in the degree of microscopic hematuria (more than 50 red blood cells per high-power field), an episode of gross hematuria or the new onset of irritative voiding symptoms in the absence of infection warrants a complete reevaluation.17

Additional large population-based studies of the prevalence of asymptomatic microscopic hematuria and its relationship with age and sex are needed before definitive recommendations can be formalized to practice guidelines.

The Authors

TIMOTHY R. THALLER, M.D., is currently in private practice at Statesboro Urologic Clinic, P.C., Statesboro, Ga. He received his medical degree from Louisiana State University School of Medicine in Shreveport and completed a residency in urology at the University of Kansas Medical Center, Kansas City, Kan., where he served as chief resident.

LESTER P. WANG, M.D., is in private practice at Valley Urology Center, Renton, Wash. Dr. Wang completed a residency in urology at the University of Minnesota, Minneapolis, and a fellowship in endourology at Baylor College of Medicine, Houston.

Address correspondence to Timothy R. Thaller, M.D., Statesboro Urologic Clinic, P.C., 412 Northside Drive East, Suite 300, Statesboro, GA 30458. Reprints are not available from the authors.

The authors thank Nicolle M. DiGerolamoThaller, R.N., B.S.N., for assistance in the preparation of the manuscript, Scott M. Stanley for assistance in the laboratory and with preparation of the photomicrographs and Sue Ulrich, R.Ph., for assistance in the preparation of pharmacologic tables in the manuscript.

REFERENCES

1. Sutton JM. Evaluation of hematuria in adults. JAMA. 1990;263:2475–80.

2. Mohr DN, Offord KP, Owen RA, Melton LJ 3d. Asymptomatic microhematuria and urologic disease. A population-based study. JAMA. 1986;256:224–9.

3. Messing EM, Young TB, Hunt VB, Emoto SE, Wehbie JM. The significance of asymptomatic microhematuria in men 50 or more years old: findings of a home screening study using urinary dip-sticks. J Urol. 1987;137:919–22.

4. Britton JP, Dowell AC, Whelan P, Harris CM. A community study of bladder cancer screening by detection of occult urinary bleeding. J Urol. 1992;148:788–90.

5. Fogazzi GB, Ponticelli C. Microscopic hematuria diagnosis and management. Nephron. 1996;72:125–34.

6. Brender CB. Evaluation of the urologic patient. In: Walsh PC, ed. Campbell’s Urology. 7th ed. Philadelphia: Saunders, 1998:131–57.

7. Woolhandler S, Pels RJ, Bor DH, Himmelstein DU, Lawrence RS. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA. 1989;262:1214–9.

8. Fairley KF, Birch DF. Hematuria: a simple method for identifying glomerular bleeding. Kidney Int. 1982;21:105–8.

9. Restrepo NC, Carey PO. Evaluating hematuria in adults. Am Fam Physician. 1989;40(2):149–56.

10. Drugdex system. Englewood: Colo.: Micromedex, Inc., 1999. Accessed Sept. 24, 1998.

11. Ahmed Z, Lee J. Asymptomatic urinary abnormalities. Hematuria and proteinuria. Med Clin North Am. 1997;81:641–52.

12. Abarbanel J, Benet AE, Lask D, Kimche D. Sports hematuria. J Urol. 1990;143:887–90.

13. Gambrell RC, Blount BW. Exercise-induced hematuria. Am Fam Physician. 1996;53:905–11.

14. Jones GR, Newhouse I. Sport-related hematuria: a review. Clin J Sport Med. 1997;7:119–25.

15. Hohenfellner M, Steinbach F, Schultz-Lampel D, Schantzen W, Walter K, Cramer BM, et al. The nutcracker syndrome: new aspects of pathophysiology, diagnosis and treatment. J Urol. 1991;146:685–8.

16. Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Walsh PC, ed. Campbell's Urology. 7th ed. Philadelphia: Saunders, 1998:2327–410.

17. Mariani AJ. The evaluation of adult hematuria: a clinical update. AUA Update Series. 1998;XVII:186–91.

18. Friedenberg RM. Excretory urography in the adult. In: Walsh PC, ed. Campbell's Urology. 6th ed. Philadelphia: Saunders, 1992:412–34.

19. Dunnick NR, Sandler CM, Amis ES Jr, Newhouse JM. Functional renal anatomy, renal physiology, and contrast media. In: Mitchell CW, ed. Textbook of uroradiology. 2d ed. Baltimore: Williams & Wilkins, 1997:86–115.

20. Keizur JJ, Das S. Intravascular contrast media in urologic imaging. AUA Update Series. 1996;XV: 102–7.

21. Physicians' desk reference. 54th ed. Montvale, N.J.: Medical Economics, 2000:833.

22. Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988;169:363–5.

23. Dalrymple NC, Verga M, Anderson KR, Bove P, Covey AM, Rosenfield AT, et al. The value of unenhanced helical computerized tomography in the management of acute flank pain. J Urol. 1998;159:735–40.

24. Corwin HL, Silverstein MD. The diagnosis of neoplasia in patients with asymptomatic microscopic hematuria: a decision analysis. J Urol. 1988;139:1002–6[Published erratum in J Urol 1988;140: 1558]

25. Landman J, Chang Y, Kavaler E, Droller MJ, Liu BC. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology. 1998;52:398–402.

26. Sieber PR, Rommel FM, Huffnagle HW, Breslin JA, Agusta VE, Harpster LE. The treatment of gross hematuria secondary to prostatic bleeding with finasteride. J Urol. 1998;159:1232–3.

27. Culclasure TF, Bray VJ, Hasbargen JA. The significance of hematuria in the anticoagulated patient. Arch Intern Med. 1994;154:649–52.

28. Van Savage JG, Fried FA. Anticoagulant associated hematuria: a prospective study. J Urol. 1995;153:1594–6.


Copyright © 1999 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

More in Pubmed

Navigate this Article